Remove Government Remove IT Remove Medical Remove Medical Provider
article thumbnail

Double-Booking the Doctor is Half-Booking the Patient

A Country Doctor Writes

Ironically, back when we were jumping through the hoops of Patient Centered Medical Home recognition, we got zero credit for squeezing sick patients into our schedule the same day they called - we qualified only if we had at least one “acute” slot designated in our daily schedule, even if nobody used it. Government.

Patients 130
article thumbnail

‘Til I Hear It From Congress: FDASLA to Direct Publication of Final OTC Hearing Aid Rules

FDA Law

This provision adds nothing substantive to the OTC hearing aid regulatory scheme—it merely tells FDA that it has 30 days from enactment of the user fee legislation to issue its final rules governing OTC hearing aids. Directing FDA to issue rules isn’t out of the ordinary.

IT 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

PRESS RELEASE: Coalition Acts to Protect Pregnant Patients’ Federal Right to Emergency Care, Including Abortion

Doctors for America

This federal law has required hospitals with emergency departments to provide stabilizing treatment, including abortion, to patients experiencing medical emergencies for nearly four decades. Doctors for America’s motion to intervene was filed in Catholic Medical Association v. Department of Health and Human Services et al.,

article thumbnail

KFF Health News’ ‘What the Health?’: RFK Jr. Upends Vaccine Policy, After Promising He Wouldn’t

Physician's Weekly

Kennedy then appointed new members, including vaccine skeptics, prompting alarm from the broader medical community. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” Kennedy Jr. Anna Edney: KFF Health News’ “ Two Patients Faced Chemo.

article thumbnail

Navigating Executive Orders and DOJ Memos That Threaten Criminal Prosecution

FDA Law

Even if otherwise truthful, the promotion of off-label uses of hormones-including through informal campaigns like those conducted by sales reps or under the guise of sponsored continuing medical education courses-run afoul of the FDAs prohibitions on misbranding and mislabeling. First, it direct[s] all U.S. MedImmune, Inc. Genentech, Inc.,